Surgery Websites
LiverSource »  Faculty »  Hepatology »  Danielle Brandman, M.D., M.A.S.
Danielle Brandman, M.D., M.A.S.

Danielle Brandman, M.D., M.A.S.

Assistant Professor of Medicine
Hepatology and Liver Transplantation
Department of Medicine

Contact Information

Academic Office
 Division of Gastroenterology
513 Parnassus Avenue, Room S-357
San Francisco, CA 94143-0358
(415) 514-1094 - Phone
(415) 476-0659 - Fax
Danielle.Brandman@ucsf.edu
Open Popup

Education

  • Boston University, B.A., Biology and Psychology, 1995-1999
  • UMDNJ-New Jersey Medical School, M.D., 2001-2005
  • University of California, San Francisco, M.A.S., Clinical Research, 2009-2011

Residencies

  • University of California, San Francisco, Intern, Medicine, 2005-2006
  • University of California, San Francisco, Resident, Medicine, 2006-2008

Fellowships

  • University of California, San Francisco, Fellow, Gastroenterology, 2008-2011
  • University of California, San Francisco, Fellow, Transplant Hepatology, 2011-2012

Board Certifications

  • American Board of Internal Medicine
  • American Board of Internal Medicine - Gastroenterology

Program Affiliations

  • UCSF Liver Center

Clinical Expertise

  • Acute Liver Failure (ALF)
  • Alcoholic Liver Disease
  • Autoimmune Hepatitis
  • Choledochal Cysts
  • Cirrhosis
  • Hemochromatosis
  • Hepatitis B
  • Hepatitis C
  • Hepatocellular Carcinoma (Primary Liver Cancer)
  • Liver Transplantation
  • Living Donor Liver Transplantation
  • Non-alcoholic Fatty Liver Disease
  • Polycystic Liver Disease
  • Primary Biliary Cirrhosis
  • Primary Sclerosing Cholangitis
  • Toxic Hepatitis

Research Interests

  • Hepatitis C virus (HCV)
  • Liver injury and repair (Liver transplantation)
  • Nonalcoholic steatohepatitis (NASH)

Biography

Dr. Danielle Brandman is an Assistant Professor of Medicine and hepatologist, specializing in treating patients needing liver transplants. Her research interests include nonalcoholic fatty liver disease and post-transplant metabolic syndrome.  She engages in outcomes-based research with a special interest in NAFLD and liver transplantation: the post-transplant outcomes of patients with NAFLD, selection of patients with NAFLD for transplant, recurrence of NAFLD following transplant, and new-onset NAFLD after liver transplantation for other causes of liver disease

Dr. Brandman received her medical degree at UMDNJ New Jersey Medical School in 2005. She continued her medical training at University of California, San Francisco, where she completed her residency, gastroenterology fellowship, transplant hepatology fellowship, and master's degree in clinical research. Dr. Brandman is certified by the American Board of Internal Medicine in internal medicine and gastroenterology.  She is a member of the American Association for the Study of Liver Disease (AASLD).

Awards & Honors

  • Resident Mentor of the Year, CTSI Resident Research Program, 2016
  • Haile T. Debas Academy of Medical Educators, Excellence in Teaching Award, UCSF, 2015

Publications

Most recent publications from a total of 22
  1. Brandman D. Who Should Treat Fatty Liver Disease: Primary Care or Hepatology? Clin Liver Dis (Hoboken). 2019 Jun; 13(6):158-161. View in PubMed
  2. Adler E, Brandman D. Treatment of Fatty Liver Disease-Time to Implement Common Sense Measures. JAMA Intern Med. 2019 Jul 01. View in PubMed
  3. Brandman D, Lin H, McManus A, Agarwal S, Gache LM, Irish W, Gollob J, Živkovic SA. Evaluating Prognostic Factors for Liver Transplantation Among United States Patients With Hereditary Transthyretin-Mediated (hATTR) Amyloidosis Using National Registry Data. Prog Transplant. 2019 Sep; 29(3):213-219. View in PubMed
  4. Brandman D, Terrault NA. Alcohol use in patients with non-alcoholic fatty liver: a tangled web of causality. Hepatobiliary Surg Nutr. 2019 Jun; 8(3):277-279. View in PubMed
  5. Siddiqui MS, Yamada G, Vuppalanchi R, Van Natta M, Loomba R, Guy C, Brandman D, Tonascia J, Chalasani N, Neuschwander-Tetri B, Sanyal AJ. Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage. Clin Gastroenterol Hepatol. 2019 Aug; 17(9):1877-1885.e5. View in PubMed
  6. Siddiqui MS, Vuppalanchi R, Van Natta ML, Hallinan E, Kowdley KV, Abdelmalek M, Neuschwander-Tetri BA, Loomba R, Dasarathy S, Brandman D, Doo E, Tonascia JA, Kleiner DE, Chalasani N, Sanyal AJ. Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2019 01; 17(1):156-163.e2. View in PubMed
  7. Kushner T, Shinkai K, Fox L, Ying D, Gross A, Balitzer D, Gill R, Brandman D. New presentation of autoimmune hepatitis with erythema multiforme. Hepatology. 2018 04; 67(4):1628-1630. View in PubMed
  8. Vuppalanchi R, Siddiqui MS, Van Natta ML, Hallinan E, Brandman D, Kowdley K, Neuschwander-Tetri BA, Loomba R, Dasarathy S, Abdelmalek M, Doo E, Tonascia JA, Kleiner DE, Sanyal AJ, Chalasani N. Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease. Hepatology. 2018 01; 67(1):134-144. View in PubMed
  9. Kardashian AA, Dodge JL, Roberts J, Brandman D. Weighing the risks: Morbid obesity and diabetes are associated with increased risk of death on the liver transplant waiting list. Liver Int. 2018 03; 38(3):553-563. View in PubMed
  10. Lewin SM, Mehta N, Kelley RK, Roberts JP, Yao FY, Brandman D. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma. Liver Transpl. 2017 08; 23(8):1015-1022. View in PubMed
  11. View All Publications
Publications provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Danielle Brandman, M.D., M.A.S.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.

 

 
Site Directory
    X